Krystal Biotech EPS Basic from Tax Loss Carryforward (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

267.14 -7.45 (-2.71%) USD | NASDAQ | Feb 24, 16:00

266.90 -0.24 (-0.09%) After-Hours: 20:00

View EPS Basic from Tax Loss Carryforward (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
DexCom, Inc.	--
Alkermes Plc	--
Regeneron Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--